A Study to Test Different Doses of BI 765063 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer (Solid Tumors)
- First Posted Date
- 2020-12-04
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 18
- Registration Number
- NCT04653142
- Locations
- 🇯🇵
National Cancer Center Hospital East, Chiba, Kashiwa, Japan
🇯🇵National Cancer Center Hospital, Tokyo, Chuo-ku, Japan
🇯🇵Shikoku Cancer Center, Ehime, Matsuyama, Japan
A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19
- Conditions
- Interventions
- First Posted Date
- 2020-11-23
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 104
- Registration Number
- NCT04640194
- Locations
- 🇩🇪
Petrus-Krankenhaus, Wuppertal, Germany
🇪🇸Hospital Puerta del Mar, Cádiz, Spain
🇪🇸Hospital Vall d'Hebron, Barcelona, Spain
A Study to Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation
- Conditions
- Interventions
- First Posted Date
- 2020-11-13
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 15
- Registration Number
- NCT04627142
- Locations
- 🇨🇳
Shanghai East Hospital, Tongji University China, Shanghai, China
A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood
- First Posted Date
- 2020-11-06
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 74
- Registration Number
- NCT04619251
- Locations
- 🇯🇵
SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku, Japan
NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib
- First Posted Date
- 2020-11-04
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 214
- Registration Number
- NCT04614441
- Locations
- 🇨🇳
Tri-Service General Hospital, Taipei, Taiwan
🇨🇳E-Da Hospital, Kaohsiung, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19
- First Posted Date
- 2020-10-27
- Last Posted Date
- 2022-04-11
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 133
- Registration Number
- NCT04604184
- Locations
- 🇧🇷
Hospital Regional Hans Dieter Schmidt, Santa Catarina, Brazil
🇲🇽Hospital Cardiologica Aguascalientes, Aguascalientes, Mexico
🇺🇸St. Elizabeth's Medical Center, Boston, Massachusetts, United States
A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine
- Conditions
- Interventions
- First Posted Date
- 2020-10-26
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 40
- Registration Number
- NCT04602221
- Locations
- 🇺🇸
Hassman Research Institute, Marlton, New Jersey, United States
🇺🇸Collaborative Neuroscience Research, LLC, Long Beach, California, United States
COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR
- Conditions
- Interventions
- First Posted Date
- 2020-10-23
- Last Posted Date
- 2021-07-26
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 151
- Registration Number
- NCT04599959
- Locations
- 🇲🇽
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico, Mexico
A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body
- Conditions
- Interventions
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2023-09-06
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 15
- Registration Number
- NCT04590937
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study in Healthy Men to Test How BI 1358894 is Taken up and Handled by the Body
- First Posted Date
- 2020-09-28
- Last Posted Date
- 2021-01-13
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 15
- Registration Number
- NCT04567316
- Locations
- 🇳🇱
PRA Health Sciences Onderzoekscentrum Martini, Groningen, Netherlands